ArticleClinical and experimental vaccine research2019

One-year antibody persistence and safety of a 4-dose schedule of MenACWY-CRM in healthy infants from South Korea.

Hoan-Jong Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.